One Drop is a predictive health platform that combines continuous health sensing technology, artificial intelligence, behavior change programs, and on-demand telehealth to empower individuals to make informed decisions for better health outcomes and peak performance.

One Drop is a precision health company combining continuous diagnostics, predictive analytics and machine learning in an award-winning digital solution to deliver cost-saving outcomes for people living with diabetes and other chronic conditions. The goal: empower everyone to take proactive action for better health, peak performance, and more fulfilling lives.

LAUNCH

Neu Venture Capital

Daniel Curran

RRE Ventures

Bolt

BoxGroup

Capital Factory

FJ Labs

Jason Calacanis

Bayer

One Drop

The Fall 2023 DiabetesMine Innovation Days (#DData) are happening next week in San Diego, CA, Nov 9-10. You're invited!

D-Data—the birthplace of the #WeAreNotWaiting movement—connects healthcare leaders and the innovators behind cutting-edge digital health tools, next-gen medical devices, and programs designed to take #diabetes care to the next level. #Data2023 is sponsored by UC San Diego Health.

Interested in attending? Contact Amy Tenderich at info@diabetesmine.com.

*Discounts are available to patient entrepreneurs and advocates, researchers, and nonprofits.

https://ddataexchange.com/

Can the order in which you eat your food help prevent #diabetes? According to a new study in Nutrients MDPI, the answer is yes. 

One Drop clinical health coach Hanna Rifkin, RD, CDCES, explains the link between #foodsequencing and blood glucose levels. Plus, tips for experimenting with the increasingly popular eating practice. 

Learn more: bit.ly/46KFmdt

In the United States, nearly 1 in 3 adults (30.7%) are overweight; more than 2 in 5 adults (42.4%) have obesity. Despite the growing popularity of GLP-1 medications, employers are twice as likely to cover bariatric surgery than a GLP-1 for weight loss. Justifications for narrow coverage hinge on outrageous costs and a lack of evidence for the long-term effectiveness of anti-obesity drugs like Wegovy.

This month, Novo Nordisk, creator of Wegovy (semaglutide), challenged a long-standing narrative that for people without diabetes, #GLP1 medications are merely lifestyle products that offer cosmetic, not medical, benefits. Beyond #weightloss, their five-year clinical trial showed significant cardiovascular health benefits for patients who stay on Wegovy, citing a 20% reduction in risk of heart attack, strokes, and cardiovascular deaths.

Reuters #healthcarenews

Did you know? The Dexcom G7 seamlessly integrates with One Drop thanks to direct API integration. Continuous glucose data from Dexcom can be automatically streamed to the One Drop app, helping members living with #diabetes see a fuller picture of their health. 

Continuous glucose monitoring (#CGM) is a game changer for people living with diabetes. This technology, combined with One Drop’s one-on-one coaching, glucose predictions, and comprehensive data tracking, gives members a fuller picture of their health.

https://lnkd.in/epedRiiB

GLP-1 medications like Ozempic, Wegovy, and Trulicity offer incredible results like lower blood sugar and weight loss. But these groundbreaking medications may come with uncomfortable side effects. 

In our latest blog post, we dig into the 16 recommendations published in the Journal of Clinical Medicine for preventing and managing these gastrointestinal issues in people treated with #semaglutide or other #GLP1 receptor agonists.

Read More: joinonedrop.com/3Omt8zO

TODAY:ONEDROP

One Drop

Analysis Not Available